Study To Compare The Effectiveness of Centesimal Versus Fifty Millesimal Scale In The Management of Polycystic Ovarian Syndrome

Not Applicable

Conditions: Health Condition 1: E282- Polycystic ovarian syndrome

Registration Number: CTRI/2023/04/051971

Lead Sponsor: ehru Homoeopathic Medical College and Hospital University of Delhi

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Patients of reproductive age group(18-40 years)

2. Patients with oligomenorrhea (intermenstrual period of more than 35 days for 3 consecutive cycles) or amenorrhea for more than 3 months(2 years after menarche)

3. Patients with ultrasound findings of Polycystic ovary(the polycystic ovary had atleast one of the following: either 12 or more follicles measuring 2-9 mm in diameter or increase ovarian volume more than 10 cubic centimeter). Only one ovary fitting this definition or single occurance of one of the above criteria is sufficient to define polycystic ovary

4. Patients will clinical evidence of hirsutism

5. Patients willing to provide written informed consent

Exclusion Criteria

1. Pregnant and lactating women

2. Cases complicated with Cushing disease, hyperprolactinaemia, endometriosis and malignancies etc

3. Cases with adrenal hyperplasia and adrenal tumour

4. Ovarian tumour

5. Significant renal impairment

6. Patients who are terminally ill, under immunosuppressive treatment or self reported immunocompromised state

7. Diagnosed case of mental illness/psychiatric/ life threatening illness affecting quality of life/ any organ failure

8. Substance abuse and/or dependence

9. Patients who are unwilling to take part or not giving consent to join the study or unable to read patient information sheet

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome of the treatment will be assessed by considering the symptomatic improvement of the patient and USG finding before and after treatmentTimepoint: Before and after treatment

Secondary Outcome Measures

Name	Time	Method
Assessed by Ferriman Gallwey Scale for Hirsutism and Polycystic Ovarian Syndrome QuestionnaireTimepoint: Assess at an interval of one month till completion of study